N. Davie

发表

Cell therapy industry: billion dollar global business with unlimited potential.

C. Mason, D. Brindley, E. Culme-Seymour, 2011, Regenerative medicine.

The impact of market volatility on the cell therapy industry.

C. Mason, W. A. Sahlman, D. Brindley, 2011, Cell stem cell.

Promising growth and investment in the cell therapy industry during the first quarter of 2012.

C. Mason, W. A. Sahlman, D. Brindley, 2012, Cell stem cell.

Streamlining Cell Therapy ManufactureClinical to Commercial Scale

C. Mason, D. Brindley, E. Culme-Seymour, 2012 .

Regenerative medicine through a crisis: social perception and the financial reality.

N. Davie, D. Brindley, 2009, Rejuvenation research.

Streamlining Cell Therapy Manufacture

Chris Mason, C. Mason, D. Brindley, 2012 .

Peak serum: implications of serum supply for cell therapy manufacturing.

Chris Mason, Jon A Rowley, David A Brindley, 2012, Regenerative medicine.

Quality control in cell and tissue engineering

I. B. Wall, N. Davie, N. Davie, 2013 .

Cell therapy manufacturing: identifying and meeting demand

N. Davie, D. Brindley, J. Carmen, 2016 .

Knowledge translation in tri-sectoral collaborations: An exploration of perceptions of academia, industry and healthcare collaborations in innovation adoption.

L. Fitzgerald, R. Barker, N. Davie, 2018, Health policy.

A decade of cell therapy clinical trials (2000-2010).

Simon Edwards-Parton, Chris Mason, David A Brindley, 2012, Regenerative medicine.